July 7, 2017 / 4:13 AM / 17 days ago

BRIEF-Jiangxi Boya Bio-Pharmaceutical sees H1 FY 2017 net profit up 35 pct to 65 pct

1 Min Read

July 7(Reuters) - Jiangxi Boya Bio-Pharmaceutical Co Ltd :

* Sees H1 FY 2017 net profit to increase by 35 percent to 65 percent, or to be 142.7 million yuan to 174.4 million yuan

* Says H1 FY 2016 net profit was 105.7 million yuan

* The reasons for the forecast are increased income of blood products and other business and contribution from investment return

Source text in Chinese: goo.gl/TNWesU

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below